ImmunoPrecise Antibodies News

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 14 07:24

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 14 07:03

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 23 16:36

ImmunoPrecise Antibodies | 6-K/A: Report of foreign private issuer (related to financial reporting)

Feb 15 14:18

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 14, 2023 07:38

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 14, 2023 07:03

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 6, 2023 16:19

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 27, 2023 07:31

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 20, 2023 13:56

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 14, 2023 07:02

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 14, 2023 07:01

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 8, 2023 07:30

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 15, 2023 16:50

ImmunoPrecise Antibodies | 40-F: FY2023 Annual Report

Jul 10, 2023 15:32

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 7, 2023 07:36

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 29, 2023 08:01

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 30, 2023 11:53

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 16, 2023 07:08

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 16, 2023 07:00

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 7, 2023 07:52